91制片厂

Published on Market Research Reports庐 Inc. ()

Home > Global Iohexol API Market Growth 2024-2030

Global Iohexol API Market Growth 2024-2030

Publication ID: 
LPI01242831
Publication Date: 
January 4, 2024
Pages: 
91
Publisher: 
LPI
Countries: 
Global [1]
USD 3,660.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Manufacturing (Chemicals) [2]
Chemicals [3]
Description: 

The global Iohexol API market size was valued at US$ 495.1 million in 2023. With growing demand in downstream market, the Iohexol API is forecast to a readjusted size of US$ 803.8 million by 2030 with a CAGR of 7.2% during review period.
The research report highlights the growth potential of the global Iohexol API market. Iohexol API are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Iohexol API. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Iohexol API market.
Iohexol was first listed in Norway and Sweden in 1982. It is a kind of second-generation non-ionic monomeric contrast agent. Iopromide, Iomeprol, etc. Iohexol has low osmotic pressure, low toxicity to the nervous system, low contrast density, and good tolerance. It can be used for angiography, subarachnoid angiography, coronary angiography, spinal cord and femoral joints, urology angiography, and enhanced CT scanning. Etc., is the "gold standard" for evaluating various X-ray contrast agents in the medical community.
Global key manufacturers of Iohexol API include GE Healthcare, Otsuka Chemicals, Starry, etc. Global top three manufacturers hold a share about 85%. Europe is the largest market of Iohexol API, holds a share over 60%. In terms of product, the Original Drug holds a larger segment, with a share over 80%. And in terms of application, the largest application is Hospitals, with a share of over 90%.
Key Features:
The report on Iohexol API market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Iohexol API market. It may include historical data, market segmentation by Type (e.g., Original Drug, Generic Drug), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Iohexol API market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Iohexol API market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Iohexol API industry. This include advancements in Iohexol API technology, Iohexol API new entrants, Iohexol API new investment, and other innovations that are shaping the future of Iohexol API.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Iohexol API market. It includes factors influencing customer ' purchasing decisions, preferences for Iohexol API product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Iohexol API market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Iohexol API market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Iohexol API market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Iohexol API industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Iohexol API market.
Market Segmentation:
Iohexol API market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Original Drug
Generic Drug
Segmentation by application
Hospitals
Clinics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GE Healthcare
Otsuka Chemicals
Justesa Imagen
Starry Pharmaceutical
Haichang Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Iohexol API market?
What factors are driving Iohexol API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Iohexol API market opportunities vary by end market size?
How does Iohexol API break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Iohexol API Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Iohexol API by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Iohexol API by Country/Region, 2019, 2023 & 2030
2.2 Iohexol API Segment by Type
2.2.1 Original Drug
2.2.2 Generic Drug
2.3 Iohexol API Sales by Type
2.3.1 Global Iohexol API Sales Market Share by Type (2019-2024)
2.3.2 Global Iohexol API Revenue and Market Share by Type (2019-2024)
2.3.3 Global Iohexol API Sale Price by Type (2019-2024)
2.4 Iohexol API Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.5 Iohexol API Sales by Application
2.5.1 Global Iohexol API Sale Market Share by Application (2019-2024)
2.5.2 Global Iohexol API Revenue and Market Share by Application (2019-2024)
2.5.3 Global Iohexol API Sale Price by Application (2019-2024)
3 Global Iohexol API by Company
3.1 Global Iohexol API Breakdown Data by Company
3.1.1 Global Iohexol API Annual Sales by Company (2019-2024)
3.1.2 Global Iohexol API Sales Market Share by Company (2019-2024)
3.2 Global Iohexol API Annual Revenue by Company (2019-2024)
3.2.1 Global Iohexol API Revenue by Company (2019-2024)
3.2.2 Global Iohexol API Revenue Market Share by Company (2019-2024)
3.3 Global Iohexol API Sale Price by Company
3.4 Key Manufacturers Iohexol API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Iohexol API Product Location Distribution
3.4.2 Players Iohexol API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Iohexol API by Geographic Region
4.1 World Historic Iohexol API Market Size by Geographic Region (2019-2024)
4.1.1 Global Iohexol API Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Iohexol API Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Iohexol API Market Size by Country/Region (2019-2024)
4.2.1 Global Iohexol API Annual Sales by Country/Region (2019-2024)
4.2.2 Global Iohexol API Annual Revenue by Country/Region (2019-2024)
4.3 Americas Iohexol API Sales Growth
4.4 APAC Iohexol API Sales Growth
4.5 Europe Iohexol API Sales Growth
4.6 Middle East & Africa Iohexol API Sales Growth
5 Americas
5.1 Americas Iohexol API Sales by Country
5.1.1 Americas Iohexol API Sales by Country (2019-2024)
5.1.2 Americas Iohexol API Revenue by Country (2019-2024)
5.2 Americas Iohexol API Sales by Type
5.3 Americas Iohexol API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Iohexol API Sales by Region
6.1.1 APAC Iohexol API Sales by Region (2019-2024)
6.1.2 APAC Iohexol API Revenue by Region (2019-2024)
6.2 APAC Iohexol API Sales by Type
6.3 APAC Iohexol API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Iohexol API by Country
7.1.1 Europe Iohexol API Sales by Country (2019-2024)
7.1.2 Europe Iohexol API Revenue by Country (2019-2024)
7.2 Europe Iohexol API Sales by Type
7.3 Europe Iohexol API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Iohexol API by Country
8.1.1 Middle East & Africa Iohexol API Sales by Country (2019-2024)
8.1.2 Middle East & Africa Iohexol API Revenue by Country (2019-2024)
8.2 Middle East & Africa Iohexol API Sales by Type
8.3 Middle East & Africa Iohexol API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Iohexol API
10.3 Manufacturing Process Analysis of Iohexol API
10.4 Industry Chain Structure of Iohexol API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Iohexol API Distributors
11.3 Iohexol API Customer
12 World Forecast Review for Iohexol API by Geographic Region
12.1 Global Iohexol API Market Size Forecast by Region
12.1.1 Global Iohexol API Forecast by Region (2025-2030)
12.1.2 Global Iohexol API Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Iohexol API Forecast by Type
12.7 Global Iohexol API Forecast by Application
13 Key Players Analysis
13.1 GE Healthcare
13.1.1 GE Healthcare Company Information
13.1.2 GE Healthcare Iohexol API Product Portfolios and Specifications
13.1.3 GE Healthcare Iohexol API Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 GE Healthcare Main Business Overview
13.1.5 GE Healthcare Latest Developments
13.2 Otsuka Chemicals
13.2.1 Otsuka Chemicals Company Information
13.2.2 Otsuka Chemicals Iohexol API Product Portfolios and Specifications
13.2.3 Otsuka Chemicals Iohexol API Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Otsuka Chemicals Main Business Overview
13.2.5 Otsuka Chemicals Latest Developments
13.3 Justesa Imagen
13.3.1 Justesa Imagen Company Information
13.3.2 Justesa Imagen Iohexol API Product Portfolios and Specifications
13.3.3 Justesa Imagen Iohexol API Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Justesa Imagen Main Business Overview
13.3.5 Justesa Imagen Latest Developments
13.4 Starry Pharmaceutical
13.4.1 Starry Pharmaceutical Company Information
13.4.2 Starry Pharmaceutical Iohexol API Product Portfolios and Specifications
13.4.3 Starry Pharmaceutical Iohexol API Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Starry Pharmaceutical Main Business Overview
13.4.5 Starry Pharmaceutical Latest Developments
13.5 Haichang Pharmaceutical
13.5.1 Haichang Pharmaceutical Company Information
13.5.2 Haichang Pharmaceutical Iohexol API Product Portfolios and Specifications
13.5.3 Haichang Pharmaceutical Iohexol API Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Haichang Pharmaceutical Main Business Overview
13.5.5 Haichang Pharmaceutical Latest Developments
14 Research Findings and Conclusion

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/lpi/global-iohexol-api-market-growth-2024-2030

Links
[1] /countries/global[2] /manufacturing-chemicals[3] /chemicals